Infectious Disease and Microbiology – Bordetella Species

Overview

Bordetella pertussis and Bordetella parapertussis are aerobic Gram-negative bacilli that cause respiratory tract infection, most notably whooping cough (pertussis). The organisms occur worldwide and can infect individuals who have previously been immunized, particularly adults, because protection against pertussis decreases over time.

Microbiology

Bordetella species are small, aerobic Gram-negative bacilli with a particular tropism for the respiratory tract. B. pertussis is the major cause of classic whooping cough, whereas B. parapertussis can produce a similar, often somewhat milder, pertussis-like respiratory illness.

Epidemiology

Pertussis has a worldwide distribution. Infection can occur even in previously vaccinated individuals because vaccine-induced immunity is not lifelong. Consequently, adolescents and adults may develop infection and can serve as sources of transmission to susceptible individuals, especially young infants.

Clinical Infection

The characteristic disease is whooping cough, a highly contagious respiratory infection. Illness typically begins with nonspecific upper respiratory symptoms and subsequently progresses to episodes of severe, repetitive coughing.

The classic paroxysmal stage is characterized by repeated coughing fits that may be followed by the characteristic inspiratory “whoop.” Post-tussive vomiting can occur. Infants may not develop the classic whoop and can instead present with apnea, cyanosis, or respiratory distress.

Diagnosis

Diagnosis can be established using a nasopharyngeal specimen. PCR provides rapid detection of Bordetella DNA and is commonly useful for confirming infection.

Culture may also be performed using specialized media, classically Bordet–Gengou medium. Culture is highly specific but becomes less sensitive as the illness progresses or after antibiotic therapy has begun.

Serologic testing may provide additional diagnostic information in selected patients, particularly later in the course of illness. Antigen detection from nasopharyngeal secretions has also been described, although molecular testing is generally more useful.

Treatment

Macrolide antibiotics are the principal antimicrobial therapy for pertussis. Treatment is most effective when started early and is particularly important for reducing transmission.

Traditional regimens include erythromycin, while azithromycin and clarithromycin are commonly used alternatives because they allow shorter treatment courses and are generally better tolerated.

The source regimen lists:

Erythromycin: 2 g/day orally in four divided doses for 14 days.

Azithromycin: 500 mg orally on day 1, followed by 250 mg once daily on days 2–5.

Clarithromycin: 500 mg orally every 12 hours for 7 days.

Antibiotics given after the paroxysmal cough has become established may have limited ability to shorten the cough itself, although treatment remains valuable for decreasing bacterial transmission.

Alternative Treatment

Trimethoprim–sulfamethoxazole (TMP-SMX) may be used when macrolides cannot be given. The listed adult regimen is one double-strength tablet orally every 12 hours for 7 days.

Antibiotic selection and dosing should be adjusted for age, pregnancy, contraindications, and current treatment guidelines.

Symptomatic Management

The cough associated with pertussis can persist for weeks despite appropriate antimicrobial treatment. Conventional cough suppressants, including codeine, are generally ineffective and are not routinely useful for controlling the characteristic paroxysmal cough.

Supportive management is particularly important in infants and patients with severe disease, who may require monitoring for apnea, hypoxemia, dehydration, or feeding difficulties.

Prevention and Infection Control

Pertussis is highly transmissible through respiratory droplets. Appropriate respiratory/droplet isolation precautions are therefore important during the infectious period.

Vaccination remains the major preventive strategy. Because immunity decreases with time, booster immunization is important for maintaining population protection and reducing transmission to vulnerable infants.

High-Yield Clinical Pattern

A patient with an initial mild upper respiratory illness followed by recurrent paroxysms of severe cough, inspiratory whooping, and post-tussive vomiting should raise strong suspicion for pertussis.

The diagnosis is supported by nasopharyngeal PCR or culture, and treatment is generally with a macrolide antibiotic.

Exam Essentials

Organisms: Bordetella pertussis and Bordetella parapertussis

Microbiology: Aerobic Gram-negative bacilli

Distribution: Worldwide

Major disease: Whooping cough (pertussis)

Transmission: Respiratory droplets

Classic symptom: Paroxysmal cough with inspiratory whoop

Diagnosis: PCR or specialized culture; serology may assist in selected cases

Classic culture medium: Bordet–Gengou medium

Treatment: Macrolides, especially azithromycin, clarithromycin, or erythromycin

Alternative: TMP-SMX

Cough suppressants: Usually ineffective

Prevention: Vaccination and appropriate respiratory/droplet precautions

Important pearl: Previous vaccination does not completely exclude pertussis, particularly in adolescents and adults whose immunity has waned.

Infectious Disease and Microbiology - Bordetella bronchiseptica

Basics

Bordetella bronchiseptica is an aerobic Gram-negative bacillus that primarily colonizes and infects the respiratory tracts of animals. Human infection is uncommon, but when it occurs it most often involves the respiratory system and may be more severe in immunocompromised patients or those with chronic lung disease.

Unlike Bordetella pertussis, which is a major human respiratory pathogen, B. bronchiseptica is principally a zoonotic organism.

Microbiologic Characteristics

Bordetella bronchiseptica is:

• Gram negative

• Bacillary in shape

• Aerobic

It belongs to the genus Bordetella, but its antimicrobial susceptibility pattern differs importantly from that of B. pertussis.

Epidemiology

The organism has a worldwide distribution.

It is commonly associated with animals, particularly mammals with respiratory tract colonization or infection. Human disease is rare and usually sporadic.

Exposure to infected or colonized animals may be relevant in some cases.

Risk Factors

Human infection is more likely in patients with:

• Immunosuppression

• Chronic pulmonary disease

• Structural lung abnormalities

• Frequent animal exposure

• Severe underlying illness

Although healthy individuals can occasionally be infected, clinically significant disease is more often reported in vulnerable hosts.

Clinical Infections

Pneumonia

Pneumonia is one of the most important manifestations of B. bronchiseptica infection.

Possible symptoms include:

• Fever

• Cough

• Sputum production

• Dyspnea

• Pleuritic discomfort

• Hypoxemia in severe disease

The infection may resemble other bacterial pneumonias and therefore requires microbiologic confirmation.

Tracheobronchitis

The organism may also cause tracheobronchial infection.

Patients may develop:

• Persistent cough

• Increased respiratory secretions

• Wheezing

• Chest discomfort

• Fever

This may be especially important in patients with preexisting respiratory disease.

Bacteremia

Although uncommon, B. bronchiseptica can invade the bloodstream.

Bacteremia is more likely in:

• Immunocompromised patients

• Patients with severe pulmonary infection

• Patients with major underlying disease

Clinical findings may include:

• Fever

• Chills

• Hypotension

• Sepsis in severe cases

Diagnosis

Diagnosis is primarily established by:

Culture

Depending on the clinical syndrome, specimens may include:

• Sputum

• Bronchoalveolar lavage fluid

• Tracheal secretions

• Blood cultures

Because the organism is unusual in humans, laboratory identification is important to distinguish it from other Bordetella species and from other Gram-negative respiratory pathogens.

Treatment

A key therapeutic point is that B. bronchiseptica differs from B. pertussis.

Macrolide Resistance

In contrast to B. pertussis, B. bronchiseptica is often resistant to macrolides.

Therefore, agents such as:

• Azithromycin

• Clarithromycin

• Erythromycin

should not automatically be assumed to be effective.

Antipseudomonal Beta-Lactams

Antipseudomonal beta-lactam agents are often active.

Potential options may include agents with activity against resistant Gram-negative bacilli, depending on susceptibility results.

Definitive therapy should ideally be guided by antimicrobial susceptibility testing.

Additional Treatment Options

Other potentially active agents include:

• Aminoglycosides

• Imipenem

• Doxycycline

The choice depends on the severity of infection, site involved, renal function, and susceptibility profile.

Severe Infection

For pneumonia with bacteremia or other invasive disease, intravenous therapy is generally appropriate initially.

Management should also include:

• Oxygen support when needed

• Fluid management

• Treatment of sepsis

• Evaluation of underlying immunosuppression

• Repeat cultures if bacteremia persists

Differential Diagnosis

Respiratory infection due to B. bronchiseptica may resemble:

• Bordetella pertussis

• Pseudomonas aeruginosa

• Haemophilus influenzae

• Enteric Gram-negative pneumonia

• Other bacterial causes of tracheobronchitis

A zoonotic exposure history and culture identification help distinguish the organism.

Prevention

Because human infection is uncommon, there are no routine human vaccination recommendations specifically for B. bronchiseptica.

General preventive measures include:

• Careful hygiene after animal contact

• Avoiding close exposure to sick animals when severely immunocompromised

• Appropriate veterinary care for infected animals

• Standard infection-control practices in healthcare environments

High-Yield Clinical Pattern

Immunocompromised patient

• ●

Animal exposure

• ●

Pneumonia or tracheobronchitis

• ●

Gram-negative Bordetella isolated in culture

→ Consider Bordetella bronchiseptica

High-Yield Treatment Distinction

B. pertussis

→ Macrolides commonly used

B. bronchiseptica

→ Often macrolide resistant

→ Antipseudomonal beta-lactams, imipenem, doxycycline, or aminoglycosides may be active

Exam Essentials

Organism:

→ Bordetella bronchiseptica

Microbiology:

→ Aerobic Gram-negative bacillus

Distribution:

→ Worldwide

Major infections:

→ Pneumonia, tracheobronchitis, bacteremia

Important host:

→ Often immunocompromised or chronically ill patients

Diagnosis:

→ Culture

Key antimicrobial distinction:

→ Often resistant to macrolides

Commonly active therapy:

→ Antipseudomonal beta-lactam

Other possible agents:

→ Aminoglycosides, imipenem, doxycycline

Key clinical pearl: Unlike B. pertussis, B. bronchiseptica should not be assumed to respond to macrolides; susceptibility-guided therapy is important.

Infectious Disease and Microbiology - Blastoschizomyces capitatus

Basics

Blastoschizomyces capitatus is a rare opportunistic yeast that can cause invasive fungal disease, especially in patients with profound neutropenia or other major defects in host immunity. It can also cause fungemia in intravenous drug users and occasionally infect surgical wounds or prosthetic heart valves.

Microbiologic Characteristics

Blastoschizomyces capitatus is a yeast that can form several different fungal structures, including:

• Arthroconidia

• Hyphae

• Blastoconidia

• Pseudohyphae

This variable morphology can make identification challenging and may require careful culture-based laboratory evaluation.

Epidemiology

Human infection is uncommon but appears to occur worldwide.

The highest-risk patients are those with:

• Neutropenia

• Hematologic malignancy

• Intensive chemotherapy

• Severe immunosuppression

• Intravenous drug use in selected cases

• Prosthetic cardiac material

Clinical Infections

Disseminated Infection

The most serious manifestation is disseminated fungal disease, particularly in neutropenic patients.

Dissemination may involve:

• Bloodstream

• Skin

• Liver

• Spleen

• Other visceral organs

Patients may present with persistent fever despite broad-spectrum antibacterial therapy.

Fungemia

Fungemia is an important manifestation and may occur in severely immunocompromised patients or intravenous drug users.

Possible features include:

• Persistent fever

• Chills

• Sepsis

• Positive fungal blood cultures

• Evidence of metastatic infection

Once fungemia is identified, evaluation for deep organ involvement is important.

Skin Lesions

Disseminated disease may produce cutaneous lesions.

These may appear as:

• Papules

• Nodules

• Erythematous lesions

• Necrotic lesions in severe infection

Skin biopsy may provide a useful diagnostic specimen.

Visceral Abscesses

The fungus can seed internal organs and produce abscesses, especially in neutropenic patients.

Potential sites include:

• Liver

• Spleen

• Other deep tissues

Persistent fever, abdominal pain, or unexplained organ lesions in a high-risk patient should raise concern for invasive fungal disease.

Surgical Wound Infection

B. capitatus can occasionally infect postoperative wounds.

Clinical manifestations may include:

• Wound erythema

• Drainage

• Delayed healing

• Local tissue infection

Culture and tissue evaluation are important because routine antibacterial therapy will not treat the fungus.

Prosthetic Valve Endocarditis

A rare but serious manifestation is prosthetic valve endocarditis.

Possible findings include:

• Persistent fungemia

• Fever

• New or changing murmur

• Embolic events

• Prosthetic valve dysfunction

This form of infection may require both prolonged antifungal therapy and surgical intervention.

Diagnosis

Diagnosis is based primarily on:

• Fungal culture

• Histopathologic identification in tissue

Appropriate specimens may include:

• Blood

• Skin biopsy

• Abscess material

• Surgical wound tissue

• Cardiac valve tissue when relevant

Because the organism can produce multiple fungal forms, definitive laboratory identification may require specialized mycology methods.

Treatment

Amphotericin B

Intravenous amphotericin B has historically been a major treatment option for invasive Blastoschizomyces capitatus infection.

It is especially relevant in:

• Fungemia

• Disseminated infection

• Deep visceral disease

• Endocarditis

Treatment duration depends on the extent of infection and host recovery.

Flucytosine

Flucytosine has been used in combination with amphotericin B.

Combination therapy may be considered in severe invasive disease, particularly when susceptibility supports its use.

Fluconazole

The source lists:

Fluconazole 800 mg/day

as an additional treatment option.

However, susceptibility can vary, so antifungal therapy should ideally be guided by in vitro susceptibility testing and clinical response.

Additional Management

Neutropenia Recovery

In neutropenic patients, restoration of neutrophil function is a critical part of successful treatment.

Outcome is often better when:

• Neutropenia resolves

• Immunosuppressive therapy can be reduced

• Source control is achieved

Source Control

Depending on the infection site, management may require:

• Drainage of visceral abscesses

• Debridement of infected wounds

• Removal of infected foreign material

• Valve surgery in prosthetic valve endocarditis

Antifungal therapy alone may not be sufficient when infected prosthetic material remains in place.

Differential Diagnosis

In a neutropenic patient with fungemia or disseminated fungal disease, considerations include:

• Candida

• Trichosporon

• Geotrichum

• Aspergillus

• Other opportunistic yeasts and molds

Morphology and culture identification are essential for distinguishing these organisms.

High-Yield Clinical Pattern

Neutropenic patient

• ●

Persistent fever

• ●

Fungemia

• ●

Skin lesions or visceral abscesses

→ Consider Blastoschizomyces capitatus

Exam Essentials

Organism:

→ Blastoschizomyces capitatus

Type:

→ Opportunistic yeast

Morphologic forms:

→ Arthroconidia, hyphae, blastoconidia, pseudohyphae

Epidemiology:

→ Rare, probably worldwide

Major risk factor:

→ Neutropenia

Major infections:

→ Fungemia, disseminated disease, skin lesions, visceral abscesses

Other infections:

→ Surgical wound infection, prosthetic valve endocarditis

Diagnosis:

→ Culture and tissue biopsy

Main historical therapy:

→ Intravenous amphotericin B

Combination option:

→ Amphotericin B + flucytosine

Additional option:

→ High-dose fluconazole

Important management principle:

→ Recovery from neutropenia and source control improve outcomes

Key clinical pearl: In a neutropenic patient with persistent fungemia plus skin or visceral lesions, Blastoschizomyces capitatus should be considered among the invasive opportunistic yeasts.

Infectious Disease and Microbiology - Bipolaris Species

Basics

Bipolaris species are darkly pigmented, filamentous fungi that can cause a spectrum of infections ranging from localized corneal and subcutaneous disease to invasive pulmonary, cerebral, and disseminated infections.

Important species include:

• Bipolaris australiensis

• Bipolaris hawaiiensis

• Bipolaris spicifera

Both immunocompetent and immunocompromised individuals can develop infection.

⸻

Microbiologic Characteristics

Bipolaris species are dematiaceous fungi, meaning that melanin produces dark pigmentation within their fungal structures.

They are filamentous molds.

In culture, they typically:

• Grow relatively rapidly

• Produce cottony colonies

• Develop gray to black pigmentation

• Form hyphae at approximately 30°C

Within infected tissue, they may appear as:

• Yeast-like forms

• Pseudohyphae

• Septate pigmented hyphae

Infection caused by these pigmented fungi falls within the spectrum of phaeohyphomycosis.

⸻

Epidemiology

Bipolaris organisms are environmental fungi commonly found in:

• Soil

• Plants

• Decaying vegetation

Humans may acquire infection through:

Traumatic inoculation

Penetrating injuries can introduce fungal elements directly into the skin, subcutaneous tissues, or eye.

Another route is:

Inhalation of environmental conidia

This route is particularly relevant to sinus and pulmonary disease.

⸻

Clinical Infections

Fungal Keratitis

Bipolaris can cause mycotic keratitis, particularly after traumatic inoculation of the cornea.

Possible manifestations include:

• Eye pain

• Redness

• Photophobia

• Excessive tearing

• Corneal infiltrates

• Reduced visual acuity

Trauma involving soil or plant material is an important clinical clue.

⸻

Subcutaneous Infection

Traumatic implantation may produce localized infection of the skin and subcutaneous tissues.

Manifestations can include:

• Nodules

• Cysts

• Abscess-like lesions

• Slowly enlarging subcutaneous masses

These infections can occur even in otherwise healthy individuals.

⸻

Paranasal Sinusitis

Bipolaris is particularly associated with fungal sinus disease.

It may cause sinusitis in patients with:

• Allergic rhinitis

• Nasal polyposis

• Chronic sinonasal inflammation

It is an important cause of allergic fungal rhinosinusitis.

Patients may develop:

• Nasal obstruction

• Chronic sinus pressure

• Nasal discharge

• Recurrent sinusitis

• Nasal polyps

⸻

Pulmonary Infection

After inhalation, Bipolaris may occasionally produce pulmonary disease.

Pulmonary infection is more concerning in patients with impaired immunity and may manifest with:

• Fever

• Cough

• Dyspnea

• Pulmonary infiltrates or nodules

⸻

Central Nervous System Infection

Rarely, Bipolaris can cause severe CNS disease, including:

Meningoencephalitis

Cerebral involvement may result from direct extension or hematogenous dissemination.

Possible manifestations include:

• Headache

• Fever

• Altered mental status

• Seizures

• Focal neurologic deficits

⸻

Disseminated Infection

Immunocompromised patients are at greatest risk for invasive and disseminated disease.

The fungus may spread from a pulmonary or other primary site to multiple organs.

Disseminated infection is considerably more serious than localized cutaneous or corneal disease.

⸻

Diagnosis

Diagnosis requires demonstration and identification of the fungus in clinical specimens.

Methods include:

• Direct microscopic examination

• Histopathologic examination

• Fungal culture

⸻

Histopathology

The demonstration of pigmented septate hyphae within infected tissue is an important clue to infection by a dematiaceous fungus.

However, morphology alone may not reliably distinguish Bipolaris from other pigmented molds, so culture or molecular identification may be needed.

⸻

Culture

Fungal culture allows species identification.

Typical colonies are:

• Rapidly growing

• Cottony

• Gray to black

The dark pigmentation reflects the dematiaceous nature of the organism.

⸻

Treatment

Treatment depends heavily on the site and severity of infection.

Corneal Infection

For fungal keratitis, a traditional topical treatment is:

Topical natamycin

Urgent ophthalmologic management is important because progressive fungal keratitis can threaten vision.

⸻

Subcutaneous Infection

Localized subcutaneous infection may require:

Surgical excision

combined with antifungal therapy.

Agents that have historically been used include:

• Itraconazole

• Amphotericin B

• Ketoconazole

• Flucytosine

⸻

Systemic Infection

Severe systemic disease has traditionally been treated with:

Intravenous amphotericin B

Azole antifungals may also have activity, depending on the isolate and clinical syndrome.

⸻

Additional Antifungal Options

Other options include:

• Itraconazole

• Voriconazole

Clinical experience varies according to the infection site and species, so invasive disease should generally be managed with infectious-disease expertise and susceptibility information when available.

⸻

Surgical Management

Surgery is particularly important for accessible localized lesions.

Possible interventions include:

• Excision of subcutaneous lesions

• Debridement of infected tissue

• Surgical management of sinus disease

• Ophthalmologic procedures for severe ocular infection

Antifungal therapy and surgery are often complementary.

⸻

High-Yield Clinical Patterns

Corneal Disease

Eye trauma involving plant or soil material

Progressive keratitis

→ Consider Bipolaris fungal keratitis

Sinus Disease

Allergic rhinitis

Nasal polyps

Chronic fungal sinusitis

→ Consider a dematiaceous fungus such as Bipolaris

Immunocompromised Patient

Pulmonary infection

Neurologic manifestations or multiple organ involvement

→ Consider invasive or disseminated fungal infection

⸻

Exam Essentials

Organism:

→ Bipolaris species

Important species:

→ B. australiensis, B. hawaiiensis, B. spicifera

Type:

→ Dematiaceous filamentous fungus

Environmental reservoir:

→ Soil and plants

Transmission:

→ Traumatic inoculation or inhalation of conidia

Tissue morphology:

→ Pigmented septate hyphae

Culture:

→ Rapidly growing cottony gray-to-black colonies

Major infections:

→ Keratitis, subcutaneous infection, fungal sinusitis, pulmonary disease, meningoencephalitis, disseminated infection

Important sinus association:

→ Allergic rhinitis and nasal polyposis

Corneal treatment:

→ Topical natamycin

Localized disease:

→ Antifungal therapy + surgical excision when appropriate

Systemic disease:

→ Systemic antifungal therapy

Key clinical pearl: Bipolaris is a pigmented environmental mold that should be considered when fungal keratitis follows plant or soil trauma or when allergic fungal sinusitis occurs in a patient with nasal polyposis.

Infectious Disease and Microbiology - Bilophila wadsworthia

Basics

Bilophila wadsworthia is an anaerobic Gram-negative bacillus that can be part of the gastrointestinal microbiota. When it causes disease, it is commonly recovered as part of a polymicrobial infection, particularly in intra-abdominal infections.

Microbiologic Characteristics

Bilophila wadsworthia is:

• Gram negative

• Bacillary in shape

• Anaerobic

Because it requires anaerobic conditions for growth, appropriate specimen collection and anaerobic culture techniques are important for laboratory recovery.

Epidemiology

B. wadsworthia is most often isolated together with other aerobic and anaerobic organisms rather than as the sole pathogen.

Its clinical importance is greatest in infections involving the gastrointestinal tract and other normally sterile sites contaminated by intestinal organisms.

Clinical Infections

Intra-abdominal Infection

A major clinical association is peritonitis secondary to appendicitis.

Disruption or perforation of the gastrointestinal tract can allow the organism to enter the peritoneal cavity along with other members of the intestinal flora.

The resulting infection is commonly polymicrobial.

Bacteremia

B. wadsworthia may occasionally enter the bloodstream and cause bacteremia.

This is more likely in the setting of:

• Severe intra-abdominal infection

• Disruption of gastrointestinal integrity

• Abscess formation

• Significant underlying illness

Liver Abscess

The organism has also been associated with hepatic abscesses, usually in the context of infection arising from the gastrointestinal or biliary system.

Such infections may contain multiple aerobic and anaerobic organisms.

Diagnosis

Diagnosis is established by:

Anaerobic culture

Appropriate collection and transportation of specimens are essential because exposure to oxygen can reduce the recovery of anaerobic bacteria.

Suitable specimens may include:

• Peritoneal fluid

• Abscess material

• Blood

• Surgically obtained tissue or fluid

Treatment

Metronidazole

Metronidazole has activity against many clinically important anaerobic organisms and may be used when B. wadsworthia is susceptible.

Clindamycin

Clindamycin has also historically been used for anaerobic infections, although susceptibility should be considered because resistance among anaerobic organisms can vary.

Additional Antibiotic Options

Other agents with anaerobic activity include:

• Imipenem

• Meropenem

• Piperacillin-tazobactam

• Ticarcillin-clavulanate

• Cefoxitin

For serious polymicrobial intra-abdominal infections, therapy should provide appropriate coverage for the other expected organisms as well.

Source Control

Antibiotics alone may not be sufficient when infection is associated with:

• Perforated appendicitis

• Peritonitis

• Intra-abdominal abscess

• Liver abscess

Drainage, surgery, or other appropriate source-control procedures may therefore be necessary.

Exam Essentials

Organism:

→ Bilophila wadsworthia

Microbiology:

→ Anaerobic Gram-negative bacillus

Typical setting:

→ Mixed or polymicrobial infection

Major infections:

→ Peritonitis after appendicitis, bacteremia, liver abscess

Diagnosis:

→ Anaerobic culture

Treatment:

→ Metronidazole or another active anaerobic agent

Other options:

→ Carbapenems, piperacillin-tazobactam, cefoxitin

Important management principle:

→ Antibiotics + source control when an abscess or perforated intra-abdominal process is present

Key clinical pearl: Bilophila wadsworthia should be considered an anaerobic component of polymicrobial intra-abdominal infections rather than a common isolated pathogen.

Infectious Disease and Microbiology - Basidiobolus ranarum

Basics

Basidiobolus ranarum is a rare filamentous fungus that causes a chronic form of subcutaneous fungal infection. Disease is usually localized and slowly progressive rather than rapidly invasive.

The organism most often produces firm, painless or minimally tender nodules within the subcutaneous tissues.

Microbiologic Characteristics

Basidiobolus ranarum is a filamentous fungus, or mold.

It belongs to a group of fungi capable of producing chronic subcutaneous disease after environmental inoculation.

Epidemiology

Infection is rare but occurs worldwide.

Cases are reported more commonly from:

• India

• Indonesia

• Africa

The infection is generally associated with environmental exposure and traumatic inoculation into the skin or subcutaneous tissues.

Clinical Manifestations

The classic presentation is a chronic, nonulcerating subcutaneous lesion.

Lesions most often occur on:

• Chest

• Back

• Buttocks

• Extremities

They are usually:

• Nodular

• Firm

• Slowly enlarging

• Nonulcerating

• Located beneath the skin

Because the disease progresses slowly, it may initially be mistaken for a tumor, inflammatory lesion, or other chronic fungal infection.

Diagnosis

Diagnosis is based on:

• Fungal culture

• Histopathologic examination of tissue biopsy

Biopsy is especially helpful because it can demonstrate fungal elements within the inflammatory tissue and exclude other causes of a chronic subcutaneous mass.

Differential Diagnosis

Important considerations include:

• Sporotrichosis

• Phaeohyphomycosis

• Mycetoma

• Cutaneous tuberculosis

• Nontuberculous mycobacterial infection

• Subcutaneous tumors

• Other chronic fungal infections

Treatment

Potassium Iodide

A traditional treatment is saturated potassium iodide solution.

The source regimen describes approximately:

30 mg/kg/day for 6–12 months

Treatment is usually prolonged because of the chronic nature of the infection.

Other Antimicrobial Options

Alternative therapies that have been used include:

• Trimethoprim-sulfamethoxazole

• Ketoconazole

• Amphotericin B

The optimal regimen varies, and treatment response should be monitored clinically.

Surgical Management

Surgical excision or debridement may be helpful when lesions are:

• Localized

• Resistant to medical therapy

• Large or functionally problematic

Surgery is generally combined with antifungal treatment rather than used as the sole therapy.

Prognosis

The course is usually chronic but localized.

Spontaneous resolution has occasionally been reported, although most symptomatic cases are treated.

The prognosis is generally favorable when infection remains confined to the subcutaneous tissues.

Exam Essentials

Organism:

→ Basidiobolus ranarum

Type:

→ Filamentous fungus

Geographic association:

→ India, Indonesia, and Africa

Classic manifestation:

→ Chronic nonulcerating subcutaneous nodules

Common sites:

→ Chest, back, buttocks, extremities

Diagnosis:

→ Culture + tissue biopsy

Traditional treatment:

→ Prolonged potassium iodide

Other options:

→ TMP-SMX, ketoconazole, amphotericin B

Additional management:

→ Surgical excision for difficult localized disease

Key clinical pearl: A slowly enlarging, nonulcerating subcutaneous mass in a patient from a tropical region should raise consideration of Basidiobolus ranarum.

Infectious Disease and Microbiology - Baylisascaris procyonis

Basics

Baylisascaris procyonis is a nematode parasite, or roundworm, whose normal definitive host is the raccoon.

Humans are accidental hosts. Infection occurs after ingestion of embryonated eggs from soil or objects contaminated with raccoon feces.

Unlike ordinary intestinal helminths, the larvae do not mature normally in humans. Instead, they migrate through tissues and can cause severe visceral, ocular, and neurologic disease.

Microbiologic Characteristics

Baylisascaris procyonis is a nematode helminth.

The adult worm normally lives in the raccoon intestine, where eggs are produced and passed in feces.

After environmental maturation, these eggs become infective.

Epidemiology

Human infection is rare but is particularly recognized in North America, including the United States.

Risk is greatest where raccoons commonly contaminate:

• Soil

• Sandboxes

• Yards

• Woodpiles

• Outdoor play areas

• Raccoon latrines

Children are at particular risk because of hand-to-mouth behavior and possible ingestion of contaminated soil.

Transmission

Humans become infected by swallowing infective eggs.

The sequence is:

Raccoon feces

→ Eggs contaminate soil

→ Eggs embryonate

→ Human ingests eggs

→ Larvae hatch

→ Larvae migrate through tissues

Because humans are accidental hosts, the larvae can migrate widely rather than remaining in the intestinal lumen.

Visceral Larva Migrans

One major manifestation is visceral larva migrans.

Larvae may migrate through:

• Liver

• Lungs

• Other internal organs

Patients may develop:

• Fever

• Malaise

• Hepatomegaly

• Pulmonary symptoms

• Marked eosinophilia

The severity depends on the number of larvae ingested and the tissues involved.

Neural Larva Migrans

The most serious complication is migration into the central nervous system.

This can cause:

Eosinophilic meningoencephalitis

Possible manifestations include:

• Altered mental status

• Irritability

• Ataxia

• Weakness

• Cranial nerve abnormalities

• Seizures

• Progressive neurologic deterioration

Severe neurologic injury may be permanent.

High-Yield Pattern

Young child

• ●

Raccoon exposure

• ●

Marked eosinophilia

• ●

Progressive encephalopathy

→ Think Baylisascaris procyonis.

Ocular Larva Migrans

Larvae can also migrate into the eye.

Possible manifestations include:

• Visual loss

• Retinal inflammation

• Ocular larval lesions

• Unilateral visual disturbance

Ocular disease may be mistaken for toxocariasis or other causes of ocular larva migrans.

Diagnosis

Definitive diagnosis may be difficult.

The source emphasizes histologic identification of larvae in surgically obtained tissue.

Evaluation may also involve:

• Peripheral eosinophil count

• Neuroimaging

• Ophthalmologic examination

• Specialized serologic testing where available

Because larvae are migrating through tissues, routine stool examination is generally not useful for diagnosing human infection.

Histopathology

Larvae may be identified within involved tissue.

This can establish the diagnosis, although biopsy is often impractical in CNS disease.

Treatment

Corticosteroids

Corticosteroids may be used to reduce the inflammatory response caused by migrating or dying larvae, especially in CNS or ocular disease.

They are usually used as adjunctive therapy rather than as the sole treatment.

Anthelmintic Therapy

The older source mentions diethylcarbamazine or ivermectin as possible therapies.

In contemporary practice, early albendazole is generally regarded as the preferred antiparasitic treatment when neural or visceral baylisascariasis is suspected, often together with corticosteroids.

Treatment is most likely to be beneficial when started early, before extensive neurologic damage occurs.

Ocular Disease

For localized ocular infection, treatment may include:

• Ophthalmologic procedures

• Laser photocoagulation when the larva can be localized

• Corticosteroids

• Systemic antiparasitic therapy in selected cases

Management should involve an ophthalmologist.

Prognosis

Visceral disease can range from mild to severe.

Neurologic baylisascariasis is much more serious. Once extensive CNS injury has occurred, recovery may be incomplete despite eradication of the parasite.

Therefore, early recognition and treatment are especially important.

Prevention

The most important preventive measure is avoiding contact with raccoon feces and contaminated soil.

Important measures include:

• Keep children away from raccoon latrines.

• Prevent raccoons from nesting near homes.

• Do not handle raccoon feces with bare hands.

• Use gloves when cleaning contaminated areas.

• Wash hands thoroughly afterward.

• Prevent children from eating soil or placing contaminated objects in their mouths.

Raccoon feces should be removed carefully because the eggs are environmentally resistant.

High-Yield Comparison

Baylisascaris procyonis

Definitive host:

→ Raccoon

Human infection:

→ Accidental ingestion of eggs

Major syndromes:

→ Visceral, neural, and ocular larva migrans

Key lab clue:

→ Eosinophilia

Worst complication:

→ Severe meningoencephalitis

Diagnosis:

→ Histology or specialized testing

Treatment:

→ Early antiparasitic therapy + corticosteroids

Exam Essentials

Organism:

→ Baylisascaris procyonis

Type:

→ Nematode helminth

Definitive host:

→ Raccoon

Transmission:

→ Ingestion of infective eggs from contaminated soil

Major syndromes:

→ Visceral larva migrans, neural larva migrans, ocular larva migrans

Classic high-risk patient:

→ Young child with soil exposure

Important laboratory clue:

→ Marked eosinophilia

Severe neurologic manifestation:

→ Eosinophilic meningoencephalitis

Diagnosis:

→ Tissue identification or specialized testing

Important treatment principle:

→ Start antiparasitic therapy early when suspected

Adjunct:

→ Corticosteroids

Ocular management:

→ Ophthalmologic intervention, sometimes laser therapy

Key clinical pearl: Raccoon exposure plus eosinophilia and progressive neurologic disease is a classic warning pattern for Baylisascaris procyonis.

Infectious Disease and Microbiology - Bartonella quintana

Basics

Bartonella quintana is a small intracellular coccobacillus formerly known as Rochalimaea quintana. It is best known as the cause of trench fever, but it can also produce persistent bacteremia, endocarditis, and bacillary angiomatosis, particularly in immunocompromised patients.

Microbiologic Characteristics

Bartonella quintana is:

• A small coccobacillus

• Intracellular

• Fastidious and slow growing

Because routine cultures may fail to detect the organism promptly, specialized culture techniques and molecular methods are often useful.

Incubation Period

The incubation period is usually about:

7–30 days

After this period, patients may develop an acute or relapsing febrile illness.

Epidemiology

B. quintana has been reported from multiple endemic areas around the world, including parts of:

• Eastern Europe

• The former Soviet region

• Africa

• South America

Historically, trench fever became prominent among soldiers living in crowded and unhygienic conditions.

The principal vector is the:

Human body louse

Transmission is strongly associated with poor hygiene, crowding, and body-louse infestation.

Trench Fever

Trench fever is the classic infection caused by B. quintana.

The disease may present as an acute or relapsing febrile illness.

Typical symptoms can include:

• Fever

• Chills

• Headache

• Malaise

• Myalgias

• Bone pain, especially involving the shins

• Fatigue

The fever may recur in episodes, giving the disease a relapsing pattern.

High-Yield Clinical Pattern

Body-louse exposure

• ●

Recurrent fever

• ●

Severe shin or bone pain

→ Think trench fever due to Bartonella quintana.

Bacteremia

B. quintana can produce persistent or recurrent bacteremia.

This is especially important in socially vulnerable or immunocompromised patients.

Patients may have:

• Recurrent fever

• Malaise

• Weakness

• Few focal findings

Persistent bacteremia can predispose to infective endocarditis.

Endocarditis

Bartonella quintana is an important cause of culture-negative endocarditis.

Patients may present with:

• Prolonged fever

• Cardiac murmur

• Weight loss

• Embolic phenomena

• Heart failure in advanced disease

Routine blood cultures may remain negative because the organism is slow growing and fastidious.

Therefore, Bartonella should be considered when endocarditis is clinically suspected but standard cultures do not reveal an organism.

Bacillary Angiomatosis

In immunocompromised patients, particularly those with advanced HIV infection, B. quintana can cause bacillary angiomatosis.

The lesions are produced by abnormal vascular proliferation and may appear:

• Red

• Violaceous

• Papular

• Nodular

• Friable

They can resemble Kaposi sarcoma.

Peliosis Hepatis

Although more classically associated with B. henselae, Bartonella infection can also be associated with peliosis hepatis.

This involves blood-filled cystic spaces within the liver and may produce:

• Fever

• Abdominal pain

• Hepatomegaly

• Abnormal liver enzymes

Diagnosis

Diagnosis can be challenging because B. quintana is a fastidious organism.

Useful methods include:

• Specialized blood culture

• Cell culture

• PCR

• Serology in selected settings

Blood Culture

Lysis-centrifugation systems may improve recovery from blood.

Because growth is slow, prolonged incubation may be required.

A negative routine blood culture does not exclude Bartonella infection.

PCR

PCR is particularly helpful for detecting Bartonella DNA in:

• Blood

• Cardiac valve tissue

• Skin lesions

• Other infected tissues

Molecular testing can be especially valuable in culture-negative endocarditis.

Treatment

Bacteremia Without Endocarditis

A commonly used regimen is:

Doxycycline 100 mg orally every 12 hours for 4 weeks

plus

Gentamicin 3 mg/kg/day intravenously for the first 2 weeks

The aminoglycoside provides important bactericidal activity during the early phase of treatment.

Endocarditis

For Bartonella endocarditis, treatment is prolonged.

A commonly used regimen is:

Doxycycline 100 mg orally every 12 hours for at least 6 weeks

plus

Gentamicin 3 mg/kg/day intravenously for the first 2 weeks

Endocarditis should be managed with infectious-disease and cardiology involvement because valve destruction and heart failure may occur.

Bacillary Angiomatosis

A typical regimen is:

Doxycycline 100 mg orally every 12 hours for 3–4 months

Longer treatment may be required if immune suppression persists or relapse occurs.

Additional Treatment Options

Macrolides may also be useful, including:

• Erythromycin

• Azithromycin

Choice depends on the clinical syndrome, susceptibility considerations, drug interactions, and patient tolerance.

Prevention

The key preventive strategy is elimination of the vector:

Human body louse

Important measures include:

• Treatment of louse infestation

• Washing or replacing infested clothing and bedding

• Improving access to hygiene

• Reducing overcrowding

• Laundering clothes at appropriately high temperatures

Vector control is central because B. quintana transmission is closely linked to body lice.

High-Yield Trench Fever Pattern

Body-louse infestation

• ●

Relapsing fever

• ●

Headache and shin pain

→ Bartonella quintana

High-Yield Endocarditis Pattern

Prolonged fever

• ●

Cardiac murmur

• ●

Repeatedly negative routine blood cultures

• ●

Risk factors for body-louse exposure

→ Consider Bartonella quintana endocarditis

High-Yield Immunocompromised Pattern

Advanced immunosuppression

• ●

Red or violaceous vascular skin lesions

→ Consider bacillary angiomatosis due to Bartonella quintana or B. henselae

Exam Essentials

Organism:

→ Bartonella quintana

Former name:

→ Rochalimaea quintana

Microbiology:

→ Small intracellular coccobacillus

Vector:

→ Human body louse

Incubation:

→ 7–30 days

Classic disease:

→ Trench fever

Characteristic symptom:

→ Relapsing fever with severe shin or bone pain

Other major infections:

→ Bacteremia, endocarditis, bacillary angiomatosis

Important endocarditis clue:

→ Culture-negative endocarditis

Diagnosis:

→ Specialized blood culture, cell culture, PCR

Bacteremia treatment:

→ Doxycycline for 4 weeks + gentamicin for first 2 weeks

Endocarditis treatment:

→ Doxycycline for at least 6 weeks + gentamicin for first 2 weeks

Bacillary angiomatosis:

→ Prolonged doxycycline

Additional options:

→ Erythromycin or azithromycin

Prevention:

→ Eradicate body lice

Key distinction:

B. henselae → cats

B. quintana → body lice / trench fever

Click here to start customizing

Infectious Disease and Microbiology - Balantidium coli

Basics

Balantidium coli is a large ciliated protozoan parasite that causes balantidiasis, an intestinal infection that may range from asymptomatic colonization to severe inflammatory colitis and dysentery.

Humans are accidental hosts, and infection is usually acquired by ingestion of cysts in food or water contaminated with feces.

Microbiologic Characteristics

Balantidium coli is a protozoan.

It is notable for being a ciliated intestinal protozoan, which distinguishes it from many other medically important intestinal parasites.

The organism exists in two major forms:

• Trophozoite

• Cyst

The cyst is the infective form and allows survival outside the host.

Incubation Period

The exact incubation period is not well established.

Symptoms may begin within several days after acquisition, although the clinical course varies widely.

Epidemiology

Balantidiasis has a worldwide distribution but is more frequently recognized in:

• Latin America

• Southeast Asia

• Parts of the Middle East

Infection is more likely in areas with poor sanitation and where human food or water may be contaminated by animal or human feces.

Reservoir and Transmission

Pigs are an important reservoir for B. coli.

Transmission generally occurs by the fecal-oral route through ingestion of cysts in:

• Contaminated water

• Contaminated food

• Soil or material contaminated by feces

People who have close contact with pigs or live in areas with inadequate sanitation are at greater risk.

Clinical Manifestations

Most infections are asymptomatic.

When symptomatic disease develops, the organism can invade the colonic mucosa and cause balantidial colitis.

Symptoms may include:

• Diarrhea

• Abdominal cramps

• Abdominal pain

• Nausea

• Tenesmus

• Fever in more severe disease

Dysentery

Severe infection may produce dysentery characterized by:

• Frequent stools

• Blood in stool

• Mucus

• Abdominal pain

• Tenesmus

The clinical picture can resemble amebic dysentery or other invasive causes of colitis.

Severe Colitis

Extensive mucosal invasion may result in significant inflammation and ulceration of the colon.

Complications can include:

• Severe dehydration

• Electrolyte abnormalities

• Intestinal ulceration

• Rare perforation

Severe disease is more likely in patients who are malnourished, debilitated, or immunocompromised.

Diagnosis

Stool Examination

Diagnosis is usually made by microscopic examination of stool.

The stool should ideally be examined:

• Fresh

• After concentration when necessary

The parasite may be identified as either trophozoites or cysts.

Trophozoites

The trophozoite is large and characteristically covered with cilia.

Its motility can make it readily recognizable in a fresh stool preparation.

This is an important diagnostic clue:

Large motile ciliated protozoan in stool → think Balantidium coli.

Differential Diagnosis

Balantidial colitis should be distinguished from:

• Entamoeba histolytica infection

• Shigellosis

• Campylobacter infection

• Salmonellosis

• Inflammatory bowel disease

• Other causes of infectious dysentery

A compatible exposure history and direct visualization of the organism help establish the diagnosis.

Treatment

Tetracycline

A classic treatment regimen is:

Tetracycline 500 mg orally every 6 hours for 10 days

This has historically been considered a primary treatment for symptomatic balantidiasis.

Metronidazole

An alternative regimen is:

Metronidazole 750 mg orally every 8 hours for 5 days

This is another commonly used option when tetracycline is unsuitable.

Iodoquinol

Another alternative is:

Iodoquinol 650 mg orally every 8 hours for 20 days

Treatment selection depends on patient factors and medication availability.

Supportive Care

Patients with significant diarrhea or dysentery may also require:

• Oral rehydration

• Electrolyte replacement

• Intravenous fluids in severe dehydration

• Nutritional support

Prevention

Prevention focuses on interrupting fecal-oral transmission.

Important measures include:

• Safe drinking water

• Proper sanitation

• Hand washing

• Proper disposal of animal and human feces

• Washing fruits and vegetables

• Avoiding ingestion of contaminated food or water

People working closely with pigs should use good hygiene practices.

High-Yield Clinical Pattern

Pig exposure or poor sanitation

• ●

Diarrhea or dysentery

• ●

Large motile ciliated protozoan in stool

→ Balantidium coli

Exam Essentials

Organism:

→ Balantidium coli

Type:

→ Protozoan

Unique feature:

→ Ciliated protozoan

Major reservoir:

→ Pigs

Transmission:

→ Fecal-oral ingestion of cysts

Distribution:

→ Worldwide, especially Latin America, Southeast Asia, and parts of the Middle East

Most infections:

→ Asymptomatic

Symptomatic disease:

→ Colitis and dysentery

Diagnosis:

→ Fresh stool examination ± concentration

Classic microscopic clue:

→ Large motile ciliated trophozoite

First-line classic therapy:

→ Tetracycline

Alternatives:

→ Metronidazole or iodoquinol

Key clinical pearl: Balantidium coli is the classic ciliated protozoan causing human intestinal disease, especially in patients with pig exposure and dysentery.

Infectious Disease and Microbiology - Bacteroides Species

Basics

Bacteroides species are anaerobic Gram-negative bacilli that form an important component of the normal human microbiota, particularly within the gastrointestinal tract. Although they normally exist as harmless commensals, they can become important opportunistic pathogens when mucosal barriers are disrupted.

The Bacteroides fragilis group is particularly important clinically and is frequently involved in polymicrobial infections containing both aerobic and anaerobic organisms.

⸻

Important Species

Clinically recognized Bacteroides species include:

• Bacteroides fragilis

• B. thetaiotaomicron

• B. ovatus

• B. vulgatus

• B. uniformis

• B. caccae

• B. eggerthii

• B. stercoris

• B. distasonis

• B. merdae

• B. capillosus

• B. putredinis

• B. tectum

• B. ureolyticus

• Other related species

Taxonomy within this group has changed over time, so some organisms historically classified as Bacteroides have subsequently been reassigned to other genera.

⸻

Microbiologic Characteristics

Bacteroides species are:

• Gram-negative bacilli

• Obligate anaerobes

• Non-spore-forming organisms

Many species are normal inhabitants of the colon.

Despite representing only part of the normal intestinal microbiota, members of the B. fragilis group are disproportionately important causes of clinically significant anaerobic infections.

⸻

Epidemiology

Bacteroides infections occur worldwide.

Because these organisms normally colonize the gastrointestinal tract, most infections are endogenous. Disease typically develops when disruption of a mucosal barrier allows organisms to enter normally sterile tissues.

Common predisposing events include:

• Gastrointestinal perforation

• Abdominal surgery

• Trauma

• Bowel ischemia

• Appendicitis

• Diverticulitis

• Pelvic infection

• Malignancy involving the gastrointestinal tract

⸻

Polymicrobial Infection

A major characteristic of Bacteroides infection is its association with mixed aerobic-anaerobic infections.

Rather than occurring alone, Bacteroides may be isolated together with organisms such as enteric Gram-negative bacilli and other components of the normal gastrointestinal flora.

Therefore:

Disruption of bowel integrity + abscess formation + polymicrobial infection

→ strongly suggests involvement of anaerobic organisms such as Bacteroides.

⸻

Infections

Intra-Abdominal Infection

Intra-abdominal disease is among the most important manifestations of Bacteroides infection.

Clinical syndromes include:

• Intra-abdominal abscess

• Peritonitis

• Appendiceal infection

• Diverticular infection

• Postoperative abdominal infection

• Infection following gastrointestinal perforation

B. fragilis is particularly important in intra-abdominal abscess formation.

⸻

Pelvic Infection

Bacteroides species may participate in polymicrobial pelvic infections, including infections involving the female reproductive tract.

Possible manifestations include:

• Pelvic abscess

• Postoperative pelvic infection

• Other mixed anaerobic pelvic infections

⸻

Pleuropulmonary Infection

Anaerobic pulmonary infection may occur following aspiration of organisms from the upper aerodigestive tract.

Possible manifestations include:

• Aspiration pneumonia

• Lung abscess

• Necrotizing pulmonary infection

• Empyema

These infections are frequently polymicrobial.

⸻

Cervicofacial Infection

Bacteroides species may contribute to mixed anaerobic infections involving the oral cavity, head, and neck.

Possible sites include:

• Dental infections

• Deep neck infections

• Cervicofacial abscesses

These infections often contain several anaerobic and aerobic organisms simultaneously.

⸻

Brain Abscess

Anaerobic bacteria, including Bacteroides, can occasionally contribute to brain abscesses.

Potential sources include:

• Dental infection

• Chronic sinusitis

• Otogenic infection

• Hematogenous dissemination

Brain abscess requires antimicrobial therapy with adequate CNS penetration together with drainage when appropriate.

⸻

Bacteremia and Sepsis

Disruption of gastrointestinal or pelvic barriers may allow Bacteroides organisms to enter the bloodstream.

Patients may develop:

• Bacteremia

• Sepsis

• Septic shock in severe cases

Detection of Bacteroides bacteremia should prompt investigation for an underlying abdominal, pelvic, or gastrointestinal source.

⸻

Skin and Soft-Tissue Infection

Bacteroides species can participate in polymicrobial infections involving:

• Surgical wounds

• Traumatic wounds

• Deep soft tissues

• Abscesses

• Necrotic tissue

Anaerobic infection should be considered particularly when there is tissue necrosis, abscess formation, or infection near gastrointestinal or genitourinary structures.

⸻

Diagnosis

Anaerobic Culture

Diagnosis is established primarily through:

Anaerobic culture

Appropriate specimen collection is essential because exposure to oxygen may reduce recovery of anaerobic organisms.

High-quality specimens include:

• Abscess aspirates

• Deep tissue specimens

• Blood cultures

• Normally sterile body fluids

Superficial swabs are generally less useful because they may contain colonizing organisms and may not accurately represent the organisms causing deep infection.

⸻

Treatment

Metronidazole

Metronidazole has traditionally been one of the most reliable agents against clinically important Bacteroides, particularly the B. fragilis group.

It provides strong anaerobic activity and is commonly incorporated into treatment regimens for intra-abdominal and pelvic infections.

However, antimicrobial susceptibility can vary, and resistance should be considered in refractory or severe infections.

⸻

Carbapenems

Carbapenems provide broad coverage against anaerobic and aerobic organisms.

Options include:

• Imipenem

• Meropenem

• Ertapenem

These agents are particularly useful for complicated polymicrobial intra-abdominal infections when broad-spectrum treatment is required.

⸻

Beta-Lactam/Beta-Lactamase Inhibitor Combinations

Important options include:

• Piperacillin-tazobactam

• Ampicillin-sulbactam

Historically, ticarcillin-clavulanate has also been used.

These combinations provide activity against many anaerobic organisms while simultaneously covering several aerobic pathogens involved in polymicrobial infections.

⸻

Cephamycins

Agents with anaerobic activity include:

• Cefoxitin

• Cefotetan

However, resistance among Bacteroides species limits their reliability in some settings.

They should therefore not automatically be assumed to provide adequate treatment for every serious Bacteroides infection.

⸻

Tigecycline

Tigecycline has activity against many anaerobic organisms, including members of the B. fragilis group.

Its use depends on the site and severity of infection as well as susceptibility patterns and patient-specific considerations.

⸻

Antimicrobial Resistance

Antimicrobial resistance is increasingly important among Bacteroides species.

The B. fragilis group commonly produces beta-lactamases, making many unprotected beta-lactam antibiotics unreliable.

Resistance has also been reported to:

• Clindamycin

• Cephamycins

• Metronidazole, although resistance remains comparatively uncommon in many settings

Because susceptibility patterns vary geographically and over time, serious infections should be managed according to contemporary local susceptibility data whenever available.

⸻

Clindamycin Resistance

Clindamycin was historically used extensively for anaerobic infections, but resistance among Bacteroides has become sufficiently common that it is no longer reliably active empirically in many settings.

Therefore:

Do not automatically assume that clindamycin covers the B. fragilis group.

⸻

Source Control

Antibiotics alone may be insufficient for many Bacteroides infections.

Effective management frequently requires source control.

Examples include:

• Drainage of an intra-abdominal abscess

• Drainage of a pelvic abscess

• Removal of infected or necrotic tissue

• Surgical repair of gastrointestinal perforation

• Management of bowel ischemia

• Removal of infected foreign material when appropriate

This principle is particularly important in intra-abdominal infection.

⸻

Prevention

Because many Bacteroides infections originate from the patient’s own intestinal flora, prevention focuses on reducing opportunities for organisms to enter sterile tissues.

Important measures include:

• Appropriate surgical technique

• Timely management of bowel perforation

• Prevention and treatment of intra-abdominal contamination

• Appropriate perioperative antimicrobial prophylaxis when indicated

• Proper wound care

⸻

High-Yield Clinical Pattern

Bowel perforation

Polymicrobial intra-abdominal infection

Abscess formation

→ Think Bacteroides fragilis and other anaerobic organisms.

⸻

High-Yield Treatment Pattern

Serious Bacteroides infection

→ Ensure anaerobic antimicrobial coverage

Common options:

→ Metronidazole

→ Piperacillin-tazobactam

→ Carbapenem

PLUS

→ Drain the abscess or otherwise control the source when necessary

⸻

Exam Essentials

Organism:

→ Bacteroides species

Microbiology:

→ Anaerobic Gram-negative bacilli

Most clinically important group:

→ Bacteroides fragilis group

Normal habitat:

→ Gastrointestinal tract

Typical infections:

→ Intra-abdominal and pelvic infections

Characteristic infection pattern:

→ Polymicrobial infection with abscess formation

Other infections:

→ Pleuropulmonary infection, cervicofacial infection, brain abscess, bacteremia/sepsis, and skin or surgical-wound infection

Diagnosis:

→ Anaerobic culture

Classic antimicrobial:

→ Metronidazole

Broad-spectrum alternatives:

→ Carbapenems or beta-lactam/beta-lactamase inhibitor combinations

Important resistance issue:

→ Increasing resistance, particularly to clindamycin and some cephamycins

Critical management principle:

→ Source control

Key clinical pearl: When gastrointestinal contents escape into normally sterile tissue, particularly after bowel perforation or abdominal surgery, Bacteroides fragilis is one of the most important anaerobic pathogens to consider.